CPT code 43881 represents placement of gastric electrical stimulation electrodes on the antrum to treat refractory nausea and vomiting from gastroparesis, a condition that can be a complication of diabetes. The code covers a targeted surgical implant procedure used when medical therapy has failed to control symptoms. Nationally, this code is relevant across inpatient and outpatient surgical settings and for specialty gastroenterology and surgical practices managing severe gastroparesis.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical indication and service setting for CPT code 43881, typical payer coverage considerations, common modifiers used with the service, and the operational contexts where the procedure is performed. The publication also summarizes benchmarking metrics and policy updates where available, and offers clinical context on gastroparesis and the role of gastric electrical stimulation.

This summary equips billing, coding, and revenue teams, as well as clinical managers, with the practical context needed to classify the service line, anticipate site-of-service implications, and align documentation with payer requirements. Data not available in the input are noted where applicable in the detailed sections.